Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.33 USD
Change Today -0.02 / -0.46%
Volume 4.5K
ULBI On Other Exchanges
Symbol
Exchange
ULBI is not on other exchanges.
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

ultralife corp (ULBI) Key Developments

Ultralife Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Ultralife Corp. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. Revenue in the quarter grew 25%, or $3.8 million, to $19.0 million from $15.2 million for the second quarter of 2014 driven by gains in Battery & Energy Product sales. Net income from continuing operations was $0.8 million or $0.05 per basic and diluted share, compared to a net loss from continuing operations of $1.4 million, or $0.08 per diluted share, for the second quarter of 2014. Net income attributable to company was $0.8 million or $0.05 per basic and diluted share against net loss attributable to company of $1.4 million or $0.08 per basic share reported last year. Operating income was $0.82 million against operating loss of $1.3 million reported last year. Income from continuing operations before income taxes was $0.85 million against loss from continuing operations before income taxes of $1.32 million reported last year. For the quarter, the company reported total revenues of $38.1 million against $30.5 million reported in the same period last year. Net income from continuing operations was $1.3 million or $0.08 per basic and diluted share against net loss from continuing operations of $2.6 million or $0.15 per basic share reported last year. Net income attributable to company was $1.3 million or $0.08 per basic and diluted share against net loss attributable to company of $2.6 million or $0.15 per basic share reported last year. Operating income was $1.6 million against operating loss of $2.4 million reported last year. Income from continuing operations before income taxes was $1.5 million against loss from continuing operations before income taxes of $2.5 million reported last year.

Ultralife Corp. to Report Q2, 2015 Results on Jul 30, 2015

Ultralife Corp. announced that they will report Q2, 2015 results at 10:00 AM, US Eastern Standard Time on Jul 30, 2015

Ultralife Corp., Q2 2015 Earnings Call, Jul 30, 2015

Ultralife Corp., Q2 2015 Earnings Call, Jul 30, 2015

Ultralife Corp. Ratifies Bonadio & Co., LLP as Independent Registered Accounting for 2015

Ultralife Corp. at its annual meeting of shareholders held on June 2, 2015 ratified the selection of the company's independent registered accounting firm as Bonadio & Co., LLP for 2015.

Ultralife Corporation Announces Consolidated Earnings Results for the First Quarter Ended March 29, 2015

Ultralife Corporation announced consolidated earnings results for the first quarter ended March 29, 2015. Consolidated revenues for the first quarter totaled $19.2 million, representing a $3.9 million or 25.5% increase from the $15.3 million for the first quarter of 2014. The increased revenue and the resulting leverage of business model resulted in an operating profit of $0.8 million for the 2015 first quarter compared to an operating loss of $1.1 million for the 2014 period. The year-over-year improvement in operating profit of $1.9 million consisted of a $1.1 million contribution from the 25.5% increase in sales, a $0.6 million contribution from the 290 basis point improvement in gross margin and $0.2 million from lower operating expenses. This brings to adjusted EBITDA, defined as EBITDA including noncash stock-based compensation expense, of $1.5 million or 8% of sales against negative $45,000 for the first quarter of 2014. Net income was $0.5 million or $0.03 per share compared to a net loss of $1.5 million or negative $0.07 per share for the same period last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ULBI:US $4.33 USD -0.02

ULBI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arista Power Inc $0.04 USD 0.00
Brenntag AG €49.62 EUR -0.25
View Industry Companies
 

Industry Analysis

ULBI

Industry Average

Valuation ULBI Industry Range
Price/Earnings 40.2x
Price/Sales 1.0x
Price/Book 1.0x
Price/Cash Flow 36.6x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ULTRALIFE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.